Changing the landscape of pediatric cancer
Pediatric PRV · RACE for Children Act ·
Mikaela Naylon Give Kids a Chance Act
30% of FDA novel drug approvals touched by our laws
75 new drugs for kids
$10 billion in incentives for pediatric drug development
New adult cancer drugs may now be required to be studied in kids
The Mikaela Naylon Give Kids a Chance Act is Passed into Law 2.3.2026
Pediatric PRV is reauthorized
Studies of combinations of cancer drugs for kids
The Lede with Jake Tapper · 2.2026
Kids and young adults changing the landscape of pediatric cancer
Mikaela Naylon,16, MIB Agent at the FDA OSI Workshop, October 2025
Camille Brady, 23, MIB Agents Junior Advisory Board Member